Skip to content
Sigmascreening logo — Advancing breast cancer screening with innovative digital ma...

Sigmascreening

Advancing breast cancer screening with innovative digital mammography solutions from Amsterdam

Founded 2010 Venture round Total: $1.00M Biotechnology, Medical Devices

General Information

Company Name Sigmascreening
Founded Year 2010
Industries Biotechnology, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Sigmascreening. To contact Sigmascreening, visit sigmascreening.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sigmascreening compare?

A PDF of Sigmascreening and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sigmascreening soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sigmascreening

Sigmascreening is a medical device company based in Amsterdam that specializes in creating innovative products for breast cancer screening. Established in 2010 as a spin-off from the Academic Medical Center Amsterdam (AMC Amsterdam), the company is dedicated to enhancing digital mammography, the standard method for breast cancer detection. Sigmascreening is actively working on several new developments to make significant improvements in this crucial area of healthcare. The company received a €1.00M Venture Round investment on 23 June 2015 from DFZ Participaties.

Business keywords: Amsterdam, Sigmascreening, medical device company, breast cancer screening, innovative products, digital mammography, Academic Medical Center Amsterdam, AMC Amsterdam, spin-off, cancer detection, technology, health innovation

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €1.00M 1
DFZ Participaties
23 Jun 2015
Private Equity Round Undisclosed 3
Holland Capital, Life Sciences Fund Amsterdam +1
07 Mar 2014
Series A Undisclosed 1
Life Sciences Fund Amsterdam
06 Oct 2010
Seed Round Undisclosed 1
UvA VUmc AMC HvA Ventures Holding BV
17 Jul 2010

Sigmascreening Alternatives & Competitors

View All Alternatives
Sigmascreening vs

Delivering medical innovations to transform early detection of breast cancer and save women’s lives...

Growth
34 employees
Biotechnology, Health Care
Sigmascreening vs
Micrima Limited
Micrima Limited United Kingdom

Redefining Cancer Diagnostics

Series D
26 employees
Biotechnology, Health Care
Sigmascreening vs
CureMetrix
CureMetrix United States

CureMetrix supports the radiologist to improve mammography and save lives.

Series A
43 employees
AI, Biotechnology

FAQ About Sigmascreening

Advancing breast cancer screening with innovative digital mammography solutions from Amsterdam
Sigmascreening was founded in 2010.
Sigmascreening operates in Biotechnology and Medical Devices. Its work centres on Amsterdam, Sigmascreening, medical device company and breast cancer screening.
Sigmascreening has completed 4 funding rounds, raising a total of $1.00M. The latest funding stage is Venture round.
Top alternatives and competitors to Sigmascreening include Delphinus Medical Technologies, Inc., Micrima Limited, CureMetrix, Photolitec LLC, X-ZELL. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sigmascreening and Delphinus Medical Technologies, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sigmascreening, https://www.bouncewatch.com/company/sigmascreening, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout